![Matthew R. Ritter](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Matthew R. Ritter
Corporate Officer/Principal presso EQUILLIUM, INC.
Profilo
Matthew R.
Ritter is currently the Senior Vice President-Corporate Development at Equillium, Inc. He previously worked as a Principal at Lonza, Inc., Manager-Research & Development at EyeCyte, Inc., and Head-Business Development at La Jolla Pharmaceutical Co. Dr. Ritter completed his undergraduate degree at the University of California, Irvine and his doctorate degree at Keck School of Medicine of USC.
Posizioni attive di Matthew R. Ritter
Società | Posizione | Inizio |
---|---|---|
EQUILLIUM, INC. | Corporate Officer/Principal | - |
Precedenti posizioni note di Matthew R. Ritter
Società | Posizione | Fine |
---|---|---|
Lonza, Inc.
![]() Lonza, Inc. Chemicals: SpecialtyProcess Industries Lonza, Inc. provides chemical ingredient products. The company is headquartered in Allendale, NJ. | Corporate Officer/Principal | - |
LA JOLLA PHARMACEUTICAL COMPANY | Corporate Officer/Principal | - |
EyeCyte, Inc.
![]() EyeCyte, Inc. Pharmaceuticals: MajorHealth Technology EyeCyte, Inc. develops products for the treatment of retinal disease. It focuses on treatments for age-related macular degeneration (AMD) and diabetic retinopathy. The company was founded by Mohammad El-Kalay and Martin Friedlander in 2008 and is headquartered in La Jolla, CA. | Direttore Tecnico/Scientifico/R&S | - |
Formazione di Matthew R. Ritter
University of California, Irvine | Undergraduate Degree |
Keck School of Medicine of USC | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
EQUILLIUM, INC. | Health Technology |
Aziende private | 3 |
---|---|
EyeCyte, Inc.
![]() EyeCyte, Inc. Pharmaceuticals: MajorHealth Technology EyeCyte, Inc. develops products for the treatment of retinal disease. It focuses on treatments for age-related macular degeneration (AMD) and diabetic retinopathy. The company was founded by Mohammad El-Kalay and Martin Friedlander in 2008 and is headquartered in La Jolla, CA. | Health Technology |
Lonza, Inc.
![]() Lonza, Inc. Chemicals: SpecialtyProcess Industries Lonza, Inc. provides chemical ingredient products. The company is headquartered in Allendale, NJ. | Process Industries |
La Jolla Pharmaceutical Co.
![]() La Jolla Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology La Jolla Pharmaceutical Co. operates as a biopharmaceutical company. It engages in the discovery, development and commercialization of therapies intended to improve outcomes in patients suffering from life-threatening diseases. Its products portfolio include GIAPREZA and XERAVA. The company was founded in 1989 and is headquartered in San Diego, CA. | Health Technology |
- Borsa valori
- Insiders
- Matthew R. Ritter